Moreover, CD109 is responsible for the induction of EGFR-mediated STAT3 regulation in cancer tumorigenicity and aggressiveness, which might reveal a potential molecular target for the development of an effective therapeutic strategy against cervical squamous cell carcinoma. This evidence concerns the gene STAT3 and cancer.